Vistapharm Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for VISTAPHARM LLC, and what generic and branded alternatives to VISTAPHARM LLC drugs are available?
VISTAPHARM LLC has three approved drugs.
Drugs and US Patents for Vistapharm Llc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vistapharm Llc | DIGOXIN | digoxin | ELIXIR;ORAL | 213000-001 | Oct 4, 2019 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Vistapharm Llc | ACYCLOVIR | acyclovir | SUSPENSION;ORAL | 213951-001 | Jan 11, 2021 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Vistapharm Llc | AMINOCAPROIC ACID | aminocaproic acid | SOLUTION;ORAL | 212814-001 | Feb 26, 2020 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.